Prelude Therapeutics Inc(PRLD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PRLD Prelude Therapeutics Inc

盘后交易 11-15 19:22:57 EST

1.04

+0.01

+0.97%

盘后1.09

+0.05+4.81%

17:02 EST

最高1.08	最低1.00	成交量42.57万
今开1.05	昨收1.03	日振幅7.27%
总市值5,724万	流通市值1,429万	总股本5,504万
成交额44.35万	换手率3.10%	流通股本1,374万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PRLD","market":"US","secType":"STK","nameCN":"Prelude Therapeutics Inc","latestPrice":1.04,"timestamp":1731704400000,"preClose":1.03,"halted":0,"volume":425673,"hourTrading":{"tag":"盘后","latestPrice":1.09,"preClose":1.04,"latestTime":"17:02 EST","volume":2012,"amount":2109.9799736,"timestamp":1731708145303},"delay":0,"floatShares":13741291,"shares":55035170,"eps":-1.772308,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.01,"latestTime":"11-15 19:22:57 EST","open":1.05,"high":1.075,"low":1.0001,"amount":443540.4964731,"amplitude":0.072718,"askPrice":1.08,"askSize":36,"bidPrice":1.01,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":-1.772308,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1731718800000},"adr":0,"listingDate":1601006400000,"adjPreClose":1.03,"postHourTrading":{"tag":"盘后","latestPrice":1.09,"preClose":1.04,"latestTime":"17:02 EST","volume":2012,"amount":2109.9799736,"timestamp":1731708145303},"volumeRatio":0.957719,"impliedVol":3.1988,"impliedVolPercentile":0.9444},"requestUrl":"/m/hq/s/PRLD","defaultTab":"news","newsList":[{"id":"2483031726","title":"Prelude Therapeutics Incorporated盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483031726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483031726?lang=zh_cn&edition=full","pubTime":"2024-11-13 01:38","pubTimestamp":1731433100,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日01时38分，Prelude Therapeutics Incorporated股票出现异动，股价大幅跳水5.04%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.61%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113013821abbaab6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113013821abbaab6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","LENZ","PRLD"],"gpt_icon":0},{"id":"2482485741","title":"Prelude Therapeutics Incorporated盘中异动 急速跳水5.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482485741","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482485741?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:59","pubTimestamp":1731081565,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时59分，Prelude Therapeutics Incorporated股票出现波动，股价大幅下挫5.51%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.75%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108235925971a56a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108235925971a56a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4139","BK4505","LENZ"],"gpt_icon":0},{"id":"2481682757","title":"Prelude Therapeutics Incorporated盘中异动 大幅拉升5.10%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481682757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481682757?lang=zh_cn&edition=full","pubTime":"2024-11-06 00:19","pubTimestamp":1730823552,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日00时19分，Prelude Therapeutics Incorporated股票出现波动，股价急速上涨5.10%。截至发稿，该股报1.26美元/股，成交量11.4438万股，换手率0.21%，振幅4.58%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.95%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600191298e40976&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110600191298e40976&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2479703416","title":"Prelude Therapeutics Incorporated盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479703416","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479703416?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:04","pubTimestamp":1730387075,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时04分，Prelude Therapeutics Incorporated股票出现异动，股价大幅下挫5.30%。截至发稿，该股报1.25美元/股，成交量8.6139万股，换手率0.16%，振幅5.68%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为3.37%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103123043598e3fc28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103123043598e3fc28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4139","BK4505","LENZ"],"gpt_icon":0},{"id":"2479351472","title":"Prelude Therapeutics Incorporated盘中异动 股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479351472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479351472?lang=zh_cn&edition=full","pubTime":"2024-10-30 00:24","pubTimestamp":1730219078,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日00时24分，Prelude Therapeutics Incorporated股票出现波动，股价快速下挫5.33%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.11%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030002438971a2fae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030002438971a2fae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2478075488","title":"Prelude Therapeutics Inc    预计每股亏损 47 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2478075488","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478075488?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:05","pubTimestamp":1730120714,"startTime":"0","endTime":"0","summary":"   * Prelude Therapeutics Inc    预计在10月30日发布业绩报告时，季度营收将没有变化(预计)，截至2024年9月30日。*    * LSEG 的分析师平均预计 Prelude Therapeutics Inc 每股亏损 47 美分。* 华尔街对 Prelude Therapeutics Inc 的 12 个月目标价中位数为 5.00 美元，高于其上次收盘价 1.52 美元。10月28日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","PRLD"],"gpt_icon":0},{"id":"2478660808","title":"Prelude Therapeutics Incorporated盘中异动 急速跳水5.18%报1.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478660808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478660808?lang=zh_cn&edition=full","pubTime":"2024-10-25 03:49","pubTimestamp":1729799393,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日03时49分，Prelude Therapeutics Incorporated股票出现波动，股价快速下跌5.18%。截至发稿，该股报1.56美元/股，成交量29.0944万股，换手率0.53%，振幅6.71%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.45%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025034954971a222a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025034954971a222a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PRLD","BK4505"],"gpt_icon":0},{"id":"2477537862","title":"Prelude Therapeutics Incorporated盘中异动 早盘股价大跌5.11%报1.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477537862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477537862?lang=zh_cn&edition=full","pubTime":"2024-10-23 23:15","pubTimestamp":1729696540,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日23时15分，Prelude Therapeutics Incorporated股票出现异动，股价快速跳水5.11%。截至发稿，该股报1.67美元/股，成交量11.1635万股，换手率0.20%，振幅4.97%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为1.39%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023231540971a1d68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023231540971a1d68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","PRLD","LENZ"],"gpt_icon":0},{"id":"2477886456","title":"Prelude Therapeutics Incorporated盘中异动 早盘大幅跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477886456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477886456?lang=zh_cn&edition=full","pubTime":"2024-10-21 22:31","pubTimestamp":1729521067,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日22时31分，Prelude Therapeutics Incorporated股票出现异动，股价快速跳水5.26%。截至发稿，该股报1.80美元/股，成交量3.3628万股，换手率0.06%，振幅5.26%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.64%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021223108971a165d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021223108971a165d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","PRLD","BK4139"],"gpt_icon":0},{"id":"2476941702","title":"Prelude Therapeutics Incorporated盘中异动 大幅上涨5.24%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476941702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476941702?lang=zh_cn&edition=full","pubTime":"2024-10-17 00:52","pubTimestamp":1729097571,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日00时52分，Prelude Therapeutics Incorporated股票出现异动，股价大幅上涨5.24%。截至发稿，该股报2.01美元/股，成交量40.3248万股，换手率0.73%，振幅6.28%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.39%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017005252971a0adb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017005252971a0adb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","PRLD","BK4505"],"gpt_icon":0},{"id":"2474288394","title":"Prelude Therapeutics Incorporated盘中异动 股价大涨5.05%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474288394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474288394?lang=zh_cn&edition=full","pubTime":"2024-10-09 03:33","pubTimestamp":1728416016,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日03时33分，Prelude Therapeutics Incorporated股票出现波动，股价急速上涨5.05%。截至发稿，该股报2.08美元/股，成交量5.2497万股，换手率0.10%，振幅7.00%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.23%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100903333798e3b3c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100903333798e3b3c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2473967440","title":"Prelude Therapeutics Incorporated盘中异动 股价大涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2473967440","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473967440?lang=zh_cn&edition=full","pubTime":"2024-10-05 00:50","pubTimestamp":1728060652,"startTime":"0","endTime":"0","summary":"北京时间2024年10月05日00时50分，Prelude Therapeutics Incorporated股票出现异动，股价快速拉升5.29%。截至发稿，该股报1.99美元/股，成交量3.3903万股，换手率0.06%，振幅5.29%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.12%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241005005052ab67c172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241005005052ab67c172&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","PRLD","BK4505"],"gpt_icon":0},{"id":"2472614579","title":"Prelude Therapeutics Incorporated盘中异动 股价大跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472614579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472614579?lang=zh_cn&edition=full","pubTime":"2024-10-03 22:24","pubTimestamp":1727965485,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日22时24分，Prelude Therapeutics Incorporated股票出现波动，股价急速下跌5.42%。截至发稿，该股报1.92美元/股，成交量2.8365万股，换手率0.05%，振幅4.43%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.30%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003222446a1de2716&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003222446a1de2716&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRLD","LENZ","BK4505"],"gpt_icon":0},{"id":"2472588163","title":"Prelude Therapeutics Incorporated盘中异动 股价大跌5.19%报2.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472588163","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472588163?lang=zh_cn&edition=full","pubTime":"2024-10-01 02:54","pubTimestamp":1727722465,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日02时54分，Prelude Therapeutics Incorporated股票出现异动，股价大幅下跌5.19%。截至发稿，该股报2.01美元/股，成交量9.0149万股，换手率0.16%，振幅6.60%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.28%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100102542598e39e83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100102542598e39e83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRLD","BK4505","LENZ"],"gpt_icon":0},{"id":"2470298262","title":"Prelude Therapeutics Incorporated盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470298262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470298262?lang=zh_cn&edition=full","pubTime":"2024-09-26 00:39","pubTimestamp":1727282344,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日00时39分，Prelude Therapeutics Incorporated股票出现异动，股价急速跳水5.00%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.34%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409260039049719ca55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409260039049719ca55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","BK4139","PRLD"],"gpt_icon":0},{"id":"2469349435","title":"Prelude Therapeutics Incorporated盘中异动 早盘股价大跌5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469349435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469349435?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:35","pubTimestamp":1727184906,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时35分，Prelude Therapeutics Incorporated股票出现异动，股价大幅跳水5.49%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.93%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924213507a1dc36e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240924213507a1dc36e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","PRLD","LENZ"],"gpt_icon":0},{"id":"2469143542","title":"Prelude Therapeutics Incorporated盘中异动 早盘股价大跌5.88%报2.40美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469143542","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469143542?lang=zh_cn&edition=full","pubTime":"2024-09-23 22:50","pubTimestamp":1727103012,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日22时50分，Prelude Therapeutics Incorporated股票出现异动，股价大幅下挫5.88%。截至发稿，该股报2.40美元/股，成交量1.5056万股，换手率0.03%，振幅5.10%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.40%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923225012a1dbefeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923225012a1dbefeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","PRLD","LENZ"],"gpt_icon":0},{"id":"2468888570","title":"Prelude Therapeutics Incorporated盘中异动 早盘股价大涨5.33%报2.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468888570","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468888570?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:35","pubTimestamp":1726752949,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时35分，Prelude Therapeutics Incorporated股票出现波动，股价大幅拉升5.33%。截至发稿，该股报2.57美元/股，成交量10.2733万股，换手率0.19%，振幅2.87%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.88%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213549ab64a27a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213549ab64a27a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4139","BK4505","LENZ"],"gpt_icon":0},{"id":"2460007455","title":"Prelude Therapeutics Incorporated盘中异动 股价大跌5.45%报5.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460007455","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460007455?lang=zh_cn&edition=full","pubTime":"2024-08-20 22:17","pubTimestamp":1724163423,"startTime":"0","endTime":"0","summary":"北京时间2024年08月20日22时17分，Prelude Therapeutics Incorporated股票出现异动，股价大幅下跌5.45%。截至发稿，该股报5.55美元/股，成交量6370股，换手率0.01%，振幅4.86%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体跌幅为0.10%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820221704ab5ea4b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240820221704ab5ea4b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2460328790","title":"Prelude Therapeutics Incorporated盘中异动 快速拉升5.37%报5.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2460328790","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460328790?lang=zh_cn&edition=full","pubTime":"2024-08-19 21:42","pubTimestamp":1724074974,"startTime":"0","endTime":"0","summary":"北京时间2024年08月19日21时42分，Prelude Therapeutics Incorporated股票出现异动，股价大幅拉升5.37%。截至发稿，该股报5.49美元/股，成交量1.1147万股，换手率0.02%，振幅7.29%。Prelude Therapeutics Incorporated股票所在的生物技术行业中，整体涨幅为0.22%。Prelude Therapeutics Incorporated公司简介：Prelude Therapeutics Incorp 是一家临床阶段的精准肿瘤学公司，专注于发现和开发针对癌症关键驱动机制的小分子疗法，以满足高度未满足需求的癌症治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921425497199226&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081921425497199226&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRLD","BK4505","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.preludetx.com","stockEarnings":[{"period":"1week","weight":-0.189},{"period":"1month","weight":-0.4607},{"period":"3month","weight":-0.8023},{"period":"6month","weight":-0.7425},{"period":"1year","weight":-0.6962},{"period":"ytd","weight":-0.7588}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prelude Therapeutics Incorporated于2016年2月5日在特拉华州成立，是一家临床阶段的精密肿瘤学公司，致力于发现和开发针对高度未满足需求的癌症的关键驱动机制进行优化的小分子疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.117553},{"month":2,"riseRate":0.25,"avgChangeRate":0.011752},{"month":3,"riseRate":0.5,"avgChangeRate":-0.103502},{"month":4,"riseRate":0.25,"avgChangeRate":-0.112427},{"month":5,"riseRate":0.25,"avgChangeRate":-0.090292},{"month":6,"riseRate":0.25,"avgChangeRate":-0.034358},{"month":7,"riseRate":0.5,"avgChangeRate":0.154441},{"month":8,"riseRate":0.5,"avgChangeRate":0.081053},{"month":9,"riseRate":0,"avgChangeRate":-0.244964},{"month":10,"riseRate":0.4,"avgChangeRate":-0.225887},{"month":11,"riseRate":0.4,"avgChangeRate":0.21755},{"month":12,"riseRate":0.5,"avgChangeRate":0.114236}],"exchange":"NASDAQ","name":"Prelude Therapeutics Inc","nameEN":"Prelude Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Prelude Therapeutics Inc(PRLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Prelude Therapeutics Inc(PRLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Prelude Therapeutics Inc,PRLD,Prelude Therapeutics Inc股票,Prelude Therapeutics Inc股票老虎,Prelude Therapeutics Inc股票老虎国际,Prelude Therapeutics Inc行情,Prelude Therapeutics Inc股票行情,Prelude Therapeutics Inc股价,Prelude Therapeutics Inc股市,Prelude Therapeutics Inc股票价格,Prelude Therapeutics Inc股票交易,Prelude Therapeutics Inc股票购买,Prelude Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Prelude Therapeutics Inc(PRLD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Prelude Therapeutics Inc(PRLD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}